国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2010年
2期
203-205
,共3页
美托洛尔%原发性高血压%颈动脉粥样硬化
美託洛爾%原髮性高血壓%頸動脈粥樣硬化
미탁락이%원발성고혈압%경동맥죽양경화
Metoprolol%Essential hypertension%Carotid atherosclerosis
目的 探讨美托洛尔对原发性高血压患者颈动脉粥样硬化的影响.方法 将70例原发性高血压患者随机分为对照组(35例,常规治疗)和治疗组(35例,常规治疗+美托洛尔25~50 mg/d),连续治疗12周.在治疗前后测定两组患者的血清总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(KDL-C)、高密度脂蛋白胆固醇(HDL-C)及C反应蛋白(CRP);行颈动脉多普勒超声检查,记录颈动脉内膜-中层厚度(IMT),计算颈动脉斑块积分和斑块检出率.结果 治疗12周后,治疗组的CRP、IMT、颈动脉斑块积分数值及斑块检出率显著降低(P值<0.05);治疗组的CRP、IMT、颈动脉斑块积分数值及斑块检出率的降幅显著大于对照组(P值<0.05).结论 美托洛尔可以延缓颈动脉粥样硬化的发展并消退颈动脉粥样斑块.
目的 探討美託洛爾對原髮性高血壓患者頸動脈粥樣硬化的影響.方法 將70例原髮性高血壓患者隨機分為對照組(35例,常規治療)和治療組(35例,常規治療+美託洛爾25~50 mg/d),連續治療12週.在治療前後測定兩組患者的血清總膽固醇(TC)、甘油三酯(TG)、低密度脂蛋白膽固醇(KDL-C)、高密度脂蛋白膽固醇(HDL-C)及C反應蛋白(CRP);行頸動脈多普勒超聲檢查,記錄頸動脈內膜-中層厚度(IMT),計算頸動脈斑塊積分和斑塊檢齣率.結果 治療12週後,治療組的CRP、IMT、頸動脈斑塊積分數值及斑塊檢齣率顯著降低(P值<0.05);治療組的CRP、IMT、頸動脈斑塊積分數值及斑塊檢齣率的降幅顯著大于對照組(P值<0.05).結論 美託洛爾可以延緩頸動脈粥樣硬化的髮展併消退頸動脈粥樣斑塊.
목적 탐토미탁락이대원발성고혈압환자경동맥죽양경화적영향.방법 장70례원발성고혈압환자수궤분위대조조(35례,상규치료)화치료조(35례,상규치료+미탁락이25~50 mg/d),련속치료12주.재치료전후측정량조환자적혈청총담고순(TC)、감유삼지(TG)、저밀도지단백담고순(KDL-C)、고밀도지단백담고순(HDL-C)급C반응단백(CRP);행경동맥다보륵초성검사,기록경동맥내막-중층후도(IMT),계산경동맥반괴적분화반괴검출솔.결과 치료12주후,치료조적CRP、IMT、경동맥반괴적분수치급반괴검출솔현저강저(P치<0.05);치료조적CRP、IMT、경동맥반괴적분수치급반괴검출솔적강폭현저대우대조조(P치<0.05).결론 미탁락이가이연완경동맥죽양경화적발전병소퇴경동맥죽양반괴.
Objective To explore the effect of metoprolol on carotid atherosclerosis.Methods Seventy patients of essential hypertensive were randomly divided into control group ( n=35 ) and treatment group ( n=35, metoprolol 25 ~ 50 mg/d ), for twelve weeks continuously.Serum levels of total cholesterol ( TC ) triglycerides ( TG ), low-density lipoprotein holesterol ( LDL-C ), high-density lipo-protein cholesterol ( HDL-C ) and C-reactive protein were determined for both groups before and after treatment.Carotid intima-medial thickness (IMT ) was measured by ultrasound.The incidence of carotid plaque and carotid plaque scores were calculated.Results After the treatment of 12 weeks, CRP, IMT, the incidence of carotid plaque and carotid plaque scores were all significantly reduced ( P< 0.05 ).The reduction of CRP, IMT, incidence of carotid plaque and carotid plaque scores were significantly bigger in treatment group than those in control group ( P< 0.05 ).Conclusions Metoprolol can retard the progressive development of carotid atherosclerosis and the carotid artery plaque can be regressed.